Skip to main content
Case Update

Another remarkable update on this case

27th January 2021

On 21st January, Government wrote to our lawyers to say that they had cancelled, with immediate effect, all outstanding orders placed with Abingdon Health for antibody lateral flow tests, because they had failed to gain approval from the MHRA for home use of those tests. 

Government also confirmed that they won’t be placing any more orders under their existing contract with Abingdon Health. 

Abingdon Health did not disclose this to the market when it issued a trading update yesterday.

The letter from the Government Legal Department can be read here.

We expect to make further, shocking, disclosures about Government and Abingdon’s conduct in this case over the coming period. It’s only possible to take this case thanks to the support of hundreds of people.

It is only with your support that we can continue to hold Government to account. If you would like to make a donation, you can do so here.


This article is part of our Abingdon Health case

In April, Government announced that they supported the creation of the UK Rapid Test Consortium (UK-RTC). The idea was that the companies and institutions involved would create a rapid antibody test. On 2nd June, Government awarded a contract worth £10 million to Abingdon Health for the materials needed to produce the test. On 14th August, they handed Abingdon Health another contract worth a staggering £75 million.

See more about this case